EGA
HSTO

Eagle Global Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Eagle Global Advisors’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-136
Closed -$156K – 390
2017
Q2 		$156K Buy
+136
New +$166K ﹤0.01% 403

Other funds holding HSTO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Eagle Global Advisors's HSTO Position: Q3 2017 in Review

Eagle Global Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q3 2017, closing a stake of 136 shares — an estimated $156K sold.

Eagle Global Advisors first reported a position in HSTO in Q2 2017 and held it in 1 quarter. The position peaked at $156K in Q2 2017. 78 funds tracked by Wall St. Rank hold HSTO as of Q3 2017.

  • Eagle Global Advisors reported no remaining Histogen Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Eagle Global Advisors sold 136 Histogen Inc. Common Stock shares in Q3 2017, an estimated $156K.
  • Eagle Global Advisors first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 1 quarter.
  • Eagle Global Advisors's Histogen Inc. Common Stock position peaked at $156K in Q2 2017.
  • 78 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2017.

Based on Eagle Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.